中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
23期
101-102
,共2页
食道癌%胸腔镜%腹腔镜%临床效果
食道癌%胸腔鏡%腹腔鏡%臨床效果
식도암%흉강경%복강경%림상효과
Esophageal cancer%Thoracoscope%Laparoscope%Clinical effect
目的 研究食道癌患者采用胸腔镜结合腹腔镜治疗的临床疗效.方法 将120例食道癌患者患者分为对照组和试验组,各60例.对照组和试验组分别接受开胸三切口根治术及胸腔镜结合腹腔镜治疗,对比两组治疗方案的临床疗效.结果 对照组术中出血量(343±47.5)ml;术后住院(15.4±3.7)d;术后随访1~3年, 53例存活1年以上.试验组术中平均出血量为(207±32.4)ml,术后住院(11.4±2.3)d;术后随访1~3年,55例存活1年以上.结论 对食道癌患者进行胸腔镜结合腹腔镜治疗具有重要的临床治疗效果.
目的 研究食道癌患者採用胸腔鏡結閤腹腔鏡治療的臨床療效.方法 將120例食道癌患者患者分為對照組和試驗組,各60例.對照組和試驗組分彆接受開胸三切口根治術及胸腔鏡結閤腹腔鏡治療,對比兩組治療方案的臨床療效.結果 對照組術中齣血量(343±47.5)ml;術後住院(15.4±3.7)d;術後隨訪1~3年, 53例存活1年以上.試驗組術中平均齣血量為(207±32.4)ml,術後住院(11.4±2.3)d;術後隨訪1~3年,55例存活1年以上.結論 對食道癌患者進行胸腔鏡結閤腹腔鏡治療具有重要的臨床治療效果.
목적 연구식도암환자채용흉강경결합복강경치료적림상료효.방법 장120례식도암환자환자분위대조조화시험조,각60례.대조조화시험조분별접수개흉삼절구근치술급흉강경결합복강경치료,대비량조치료방안적림상료효.결과 대조조술중출혈량(343±47.5)ml;술후주원(15.4±3.7)d;술후수방1~3년, 53례존활1년이상.시험조술중평균출혈량위(207±32.4)ml,술후주원(11.4±2.3)d;술후수방1~3년,55례존활1년이상.결론 대식도암환자진행흉강경결합복강경치료구유중요적림상치료효과.
Objective To study on esophageal cancer patients with thoracoscopy combined with the clinical efifcacy of laparoscopic treatment. Methods Divided the 120 esophageal cancer patients into the control group and the experimental group, each group had 60 cases. The control group and the experimental group patients will undergo three incision thoracotomy radical and laparoscopic treatment, compared two groups of clinical curative effect of treatment.Results The amount of bleeding in the control group ( 343±47.5 ) ml; postoperative hospitalization ( 15.4 ± 3.7 ) d, postoperative follow-up of 1 to 3 years, 53 cases survived more than 1 years. The average bleeding amount in the experimental group was ( 207 ±32.4 ) ml, postoperative hospitalization ( 11.4 ±2.3 ) d, postoperative follow-up was 1 to 3 years, 55 cases survived more than 1 years.Conclusion Thoracoscopy combined with laparoscopic treatment in patients with esophageal cancer has important clinical treatment effect.